HHS (Harte-Hanks, Inc. Common Stock)
Insider Trading Activity
Every open-market purchase and sale reported by HHS officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.
| Filed | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-06-05 | David Scott Fisher | President | MIXED | — | — |
| 2025-12-15 | Genevieve Claire Combes | Director | A | — | — |
| 2025-12-11 | Bradley Louis Radoff | Director | A | — | — |
| 2025-07-03 | Robert T. Wyman | General Counsel | A | — | — |
| 2025-07-03 | DAVID A GARRISON | Chief Financial Officer | A | — | — |
| 2025-05-30 | Gary Stephen Rosenbach | 10%+ Owner | Buy | — | — |
| 2025-05-28 | Bradley Louis Radoff | Director | J | — | — |
| 2025-05-27 | JOHN H GRIFFIN JR | Director | J | — | — |
| 2025-05-27 | Elizabeth Ross | Director | J | — | — |
| 2025-05-27 | Robert T. Wyman | General Counsel | MIXED | — | — |
| 2025-03-05 | Robert T. Wyman | General Counsel | MIXED | — | — |
| 2024-12-06 | Bradley Louis Radoff | Director | Buy | — | — |
| 2024-12-05 | Bradley Louis Radoff | Director | Buy | — | — |
| 2024-11-25 | DAVID A GARRISON | Chief Financial Officer | Buy | — | — |
| 2024-11-18 | DAVID A GARRISON | Chief Financial Officer | Buy | — | — |
| 2024-08-19 | JOHN H GRIFFIN JR | Director | J | — | — |
| 2024-08-19 | Bradley Louis Radoff | Director | J | — | — |
| 2024-08-15 | Bradley Louis Radoff | Director | Buy | — | — |
| 2024-08-12 | Kirk A Davis | Chief Executive Officer | Buy | — | — |
| 2024-08-12 | DAVID A GARRISON | Chief Financial Officer | Buy | — | — |
| 2024-08-07 | Robert T. Wyman | General Counsel | MIXED | — | — |
| 2024-05-31 | Elizabeth Ross | Director | A | — | — |
| 2024-05-31 | JOHN H GRIFFIN JR | Director | A | — | — |
| 2024-05-31 | Bradley Louis Radoff | Director | A | — | — |
| 2024-05-31 | Genevieve Claire Combes | Director | A | — | — |
| 2024-05-29 | Robert T. Wyman | General Counsel | MIXED | — | — |
| 2024-05-17 | Bradley Louis Radoff | Director | — | — | — |
| 2024-05-15 | Bradley Louis Radoff | Director | Buy | — | — |
| 2024-05-13 | DAVID A GARRISON | Chief Financial Officer | Buy | — | — |
| 2024-05-13 | Kirk A Davis | Chief Executive Officer | Buy | — | — |
| 2024-03-04 | Robert T. Wyman | General Counsel | A | — | — |
| 2024-02-01 | DAVID A GARRISON | Chief Financial Officer | A | — | — |
| 2023-12-05 | Bradley Louis Radoff | Director | Buy | — | — |
| 2023-12-04 | Bradley Louis Radoff | Director | Buy | — | — |
| 2023-11-29 | Bradley Louis Radoff | Director | Buy | — | — |
| 2023-11-16 | Kirk A Davis | Chief Executive Officer | Buy | — | — |
| 2023-08-21 | DAVID L COPELAND | Director | A | — | — |
| 2023-08-21 | Genevieve Claire Combes | Director | A | — | — |
| 2023-08-21 | Bradley Louis Radoff | Director | A | — | — |
| 2023-08-21 | JOHN H GRIFFIN JR | Director | A | — | — |
| 2023-08-18 | JOHN H GRIFFIN JR | Director | Buy | — | — |
| 2023-08-18 | JOHN H GRIFFIN JR | Director | Buy | — | — |
| 2023-08-16 | Kirk A Davis | Chief Executive Officer | Buy | — | — |
| 2023-08-15 | Kirk A Davis | Chief Executive Officer | A | — | — |
| 2023-08-08 | LAURILEE KEARNES | Chief Financial Officer | F | — | — |
| 2023-08-08 | Robert T. Wyman | General Counsel | F | — | — |
| 2023-05-26 | LAURILEE KEARNES | Chief Financial Officer | F | — | — |
| 2023-05-26 | Brian Linscott | Chief Executive Officer | F | — | — |
| 2023-05-26 | Robert T. Wyman | General Counsel | F | — | — |
| 2023-05-24 | Brian Linscott | Chief Executive Officer | Buy | — | — |
| Insider | Role | Shares Held | Value |
|---|---|---|---|
| — | 10%+ Owner | 761,733 | — |
| — | Director | 660,938 | — |
| — | Chief Executive Officer | 430,500 | — |
| — | Chief Executive Officer | 328,985 | — |
| — | President and CEO | 231,455 | — |
| — | Director | 209,820 | — |
| — | Director | 197,658 | — |
| — | Director | 110,902 | — |
| — | Director | 105,228 | — |
| — | 10%+ Owner | 100,000 | — |
| — | Chief Financial Officer | 91,278 | — |
| — | President | 72,124 | — |
| — | Director | 64,272 | — |
| — | President and CEO | 49,829 | — |
| — | Director | 42,499 | — |
| — | Director | 39,909 | — |
| — | General Counsel | 35,551 | — |
| — | Director | 31,992 | — |
| — | Chief Executive Officer | 29,413 | — |
| — | Director | 25,414 | — |
| — | Chief Financial Officer | 25,000 | — |
| — | Director | 21,598 | — |
| — | Chief Executive Officer | 18,231 | — |
| — | President and CEO | 16,319 | — |
| — | President and COO | 15,541 | — |
Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.
Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.
Full filing history and per-insider positions are on the HHS quote page; the site-wide leaderboard is on the insider transactions hub.